Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by StockscoutXon Jun 24, 2021 6:18pm
171 Views
Post# 33448435

RE:I'm looking forward to the new board members being added.

RE:I'm looking forward to the new board members being added.We heard most of it when they reverse split 8:1 the last time and look where we are now! This time around they added more fluff for the 2:1 reverse split. This reverse split of 2:1 is really not in the best interest of shareholders but mostly for insiders and to satisfy the requirements of their new deal with Care Oncology Group. Furthermore, after the reverse split new shares will be emitted to Care Oncology Group causing further losses for current shareholders through dilution.

Nailbiter1 wrote:
Q1. Why is the Company proposing a share consolidation?

A1. StageZero has included a resolution for a 2 to 1 share consolidation at its upcoming AGM because this is the best time to vote on such resolutions. Approval of the right to consolidate is for the purposes as outlined below: At the Meeting, the Shareholders will be asked to consider and, if deemed advisable, pass a special resolution (the “Share Consolidation Resolution”) authorizing a consolidation of the Corporation’s common shares on the basis of up to two (2) preconsolidation common shares for each one post-consolidation common share (the “Share Consolidation”). Approval of the Share Consolidation Resolution does not necessarily mean that the Board will implement the Consolidation. Even if the Share Consolidation Resolution is approved by shareholders at the Meeting, and accepted by the TSX, the Board will have the discretion not to proceed with the Consolidation.

Background to and Reasons for the Share Consolidation

The Board believes that it is in the best interests of the Corporation to reduce the number of outstanding common shares by way of the Share Consolidation. The potential benefits of the Share Consolidation include:

1. Preparation for potential US listing: the Corporation is looking to prepare for a possible future listing on NASDAQ or other senior US stock exchange. The higher anticipated price of the post-consolidation common shares may help make the Corporation eligible for such a listing.

2. Greater investor interest: the current share structure of the Corporation may make it more difficult for the Corporation to attract the additional equity financing required to maintain the Corporation or to further develop its products. A share consolidation may have the effect of raising, on a proportionate basis, the price of the common shares, which could appeal to certain investors that find shares valued above certain prices to be more attractive from an investment perspective.

3. Raise additional capital at a higher price per share: the higher anticipated price of the post-consolidation common shares may allow the Corporation to raise additional capital through the sale of additional common shares at a higher price per common share than would be possible in the absence of the Share Consolidation.

4. A tighter share structure could potentially make the Corporation less attractive to computerized algorithmic trading. This in turn would allow the share price to rise with less downward pressure from day trading.

Q2. Why are the shareholders not voting on the additional directors from the Health Clinics Acquisition?

A2. The Board of SZLS will undergo significant change over the next few months. The addition of Health Clinics/Care Oncology Directors will occur after the acquisition has closed. In addition to this, SZLS is intending to ensure the Board is fully reflective of the diversity in the marketplace. Directors to be elected in connection with the Health Clinics acquisition will be proposed at the shareholder meeting to approve the Contingent Consideration shares.

Q3. Will the shares that are being used to pay for the HC acquisition be pre consolidation or post consolidation?

A3. All share figures announced in relation to the Health Clinics acquisition are on a current, or pre-consolidation basis. If a share consolidation is effected prior to the Health Clinics acquisition closing, the number of StageZero shares to be issued in connection with the acquisition would be adjusted accordingly.


The new members from HC and CO are going to be an integral part of our direction and a place for them at the table will be mandatory.
I know this is a good thing. I hope the present board remains.
There are key players there.
They are owners of companies that will be of benefit to StageZero.

Moving forward boys and girls. Maybe not as fast as some of the pre-mature efapulators would like but for me, it's a steady and positive course.

I will be voting on the 27th but my mind is already made up.

For the BOD.
For the CEO.
For the the RS.





<< Previous
Bullboard Posts
Next >>